Clinical Trial Update: Cardiovascular Risk Early Screening and Warning in Harbin : A Prospective Cohort Study

View source ↗

Summary

A prospective cohort study in Harbin evaluating early screening and warning for cardiovascular risk is described, with recruitment not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Snippet

Sponsor: Harbin Medical University | Conditions: Cardiovascular Diseases | Status: NOT_YET_RECRUITING